ACTA MEDICA MEDITERRANEA, cilt.37, sa.5, ss.2593-2597, 2021 (SCI-Expanded)
Introduction: Immunocompromised patients, SARS-CoV-2 infection might have a more severe course and may cause pneumonia quicker, compared to normal hosts. The presence of comorbid diseases increases this risk even further. In our study, we aimed to determine the clinical course and severity of COVID-19 in immunocompromised patients.